Cheng Du Sheng Nuo Biotec Co. Ltd. A Working Capital to Net Assets Ratio
Cheng Du Sheng Nuo Biotec Co. Ltd. A working capital to net assets ratio. Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) has a Working Capital to Net Assets ratio of 26.3% as of September 2025. Working capital of CN¥271.28 Million (current assets of CN¥865.79 Million minus current liabilities of CN¥594.51 Million) is measured against net assets of CN¥1.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)
Working capital to net assets ratio of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024. This chart shows how Cheng Du Sheng Nuo Biotec Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 26.3%, reflecting working capital of CN¥271.28 Million against net assets of CN¥1.03 Billion CNY. See Cheng Du Sheng Nuo Biotec Co. Ltd. A defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Cheng Du Sheng Nuo Biotec Co. Ltd. A Working Capital to Net Assets Ratio by Year (2017–2024)
Cheng Du Sheng Nuo Biotec Co. Ltd. A working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 688117 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.0% | CN¥174.75 Million | CN¥918.32 Million | CN¥718.21 Million | CN¥543.46 Million | ▼ -22.8 pp |
| 2023 | 41.8% | CN¥368.03 Million | CN¥880.10 Million | CN¥609.30 Million | CN¥241.28 Million | ▼ -11.5 pp |
| 2022 | 53.3% | CN¥440.89 Million | CN¥826.74 Million | CN¥665.89 Million | CN¥225.00 Million | ▼ -9.0 pp |
| 2021 | 62.4% | CN¥489.55 Million | CN¥785.14 Million | CN¥652.01 Million | CN¥162.46 Million | ▲ +18.7 pp |
| 2020 | 43.7% | CN¥191.07 Million | CN¥437.57 Million | CN¥336.09 Million | CN¥145.02 Million | ▼ -0.3 pp |
| 2019 | 44.0% | CN¥165.59 Million | CN¥376.46 Million | CN¥296.85 Million | CN¥131.27 Million | ▲ +1.9 pp |
| 2018 | 42.1% | CN¥137.86 Million | CN¥327.35 Million | CN¥274.37 Million | CN¥136.51 Million | ▲ +9.9 pp |
| 2017 | 32.2% | CN¥77.90 Million | CN¥241.74 Million | CN¥162.78 Million | CN¥84.88 Million | — |